Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Genome Medicine|November 2, 2016
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinomaFilemon S Dela Cruz, Daniel Diolaiti, Andrew T Turk, et al.
Nature Genetics|January 14, 2014
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasTeresa Palomero, Lucile Couronné, Hossein Khiabanian, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Blood Cancer Discovery|September 14, 2020
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemiaAnna C McCarter, Giusy Della Gatta, Ashley Melnick, et al.
JCI Insight|October 24, 2022
Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse modelDeanna M Marchionini, Jeh-Ping Liu, Alberto Ambesi-Impiombato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 23, 2016
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemiaKoichi Oshima, Hossein Khiabanian, Ana C da Silva-Almeida, et al.
Nature Cancer|April 2, 2021
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemiaKoichi Oshima, Junfei Zhao, Pablo Pérez-Durán, et al.
Pageof 4